Jules Grégory

Jules Grégory

Auto-generated profile, based on publicly available information

Jules Grégory

Department of Radiology, CRI Inserm 1149, Université Paris Cité, FHU MOSAIC², AP-HP Hôpital Beaujon, Clichy, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Medical Image Analysis
Verified
Journal Article
Closed access
CGChassagnon Guillaume
Chassagnon Guillaume
MVMaria Vakalopoulou
Maria Vakalopoulou
EBEnzo Battistella
Enzo Battistella
SCStergios Christodoulidis
Stergios Christodoulidis
THtrieu-nghi HOANG-THI
trieu-nghi HOANG-THI
NPNikos Paragios
Nikos Paragios
1

3 September 2018 in Acta Orthopaedica
Verified
Journal Article
Open access
TGThomas M Gregory
Thomas M Gregory
JGJules Gregory
Jules Gregory
JSJohn Sledge
John Sledge
RARomain Allard
Romain Allard
OMOlivier Mir
Olivier Mir
(2018). Surgery guided by mixed reality: presentation of a proof of concept. Acta Orthopaedica: Vol. 89, No. 5, pp. 480-483.

1 October 2021 in Radiology
Verified
Journal Article
Closed access
MRMarie Pierre Revel
Marie Pierre Revel
SBSamia Boussouar
Samia Boussouar
CMConstance de Margerie-Mellon
Constance de Margerie-Mellon
ISInès Saab
Inès Saab
TLThibaut Lapotre
Thibaut Lapotre
HAHendy Abdoul
Hendy Abdoul
Using reverse transcription–polymerase chain reaction as the reference standard in 10 735 patients with suspected COVID-19 pneumonia, CT was 80% accurate and was also predictive of death or need fo... Background There are conflicting data regarding the diagnostic performance of chest CT for COVID-19 pneumonia. Disease extent at CT has been reported to influence prognosis. Purpose To create a lar...

1 February 2021 in Radiology
Verified
Journal Article
Closed access
GHGuillaume HERPE
Guillaume HERPE
MLMathieu Lederlin
Mathieu Lederlin
MNMathieu Naudin
Mathieu Naudin
MOMickaël Ohana
Mickaël Ohana
KCKathia Chaumoitre
Kathia Chaumoitre
JTJean Pierre Tasu
Jean Pierre Tasu
Background The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. Purpose To evaluate the French national expe...

12 February 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
PRPascal Rousset
Pascal Rousset
JGJules Gregory
Jules Gregory
CRChristine Rousset-Jablonski
Christine Rousset-Jablonski
JHJustine Hugon-Rodin
Justine Hugon-Rodin
JRJean-François Regnard
Jean-François Regnard
MRMarie Pierre Revel
Marie Pierre Revel

1 June 2020 in JHEP Reports
Verified
Journal Article
Open access
JGJules Gregory
Jules Gregory
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
GCGiuseppe Corrias
Giuseppe Corrias
VVValérie Vilgrain
Valérie Vilgrain
MRMaxime Ronot
Maxime Ronot
The goal of assessing tumour response on imaging is to identify patients who are likely to benefit - or not - from anticancer treatment, especially in relation to survival. The World Health Organization was the first to develop assessment criteria. This early score, which assessed tumour burden by standardising lesion size measurements, laid the groundwork for many of the criteria that followed. This was then improved by the Response Evaluation Criteria in Solid Tumours (RECIST) which was quickly adopted by the oncology community. At the same time, many interventional oncology treatments were developed to target specific features of liver tumours that result in significant changes in tumours but have little effect on tumour size. New criteria focusing on the viable part of tumours were therefore designed to provide more appropriate feedback to guide patient management. Targeted therapy has resulted in a breakthrough that challenges conventional response criteria due to the non-linear relationship between response and tumour size, requiring the development of methods that emphasize the appearance of tumours. More recently, research into functional and quantitative imaging has created new opportunities in liver imaging. These results have suggested that certain parameters could serve as early predictors of response or could predict later tumour response at baseline. These approaches have now been extended by machine learning and deep learning. This clinical review focuses on the progress made in the evaluation of liver tumours on imaging, discussing the rationale for this approach, addressing challenges and controversies in the field, and suggesting possible future developments.